Full Press Release Details
Lexaria Closes 51% Acquisition of PoViva Tea,
Kelowna, BC / December 12, 2014 / Lexaria, Corp. (LXRP)
(CSE:LXX) (the Company ) is pleased to announce it has closed the 51%
acquisition of Poviva Tea, LLC.
As the final part of the closing, Lexaria has issued 119,047
restricted common shares of the Company to each of the two founders of PoViva
All issued shares will be subject to a hold period, for any
resale into the USA under Rule 144, of six months and one day. The share
issuance is subject to normal regulatory approvals. The securities referred
to herein will not be or have not been registered under the United States
Securities Act of 1933, as amended, and may not be offered or sold in the United
States absent registration or an applicable exemption from registration
Lexaria's shares are quoted in the USA with symbol LXRP and in
Canada with symbol LXX. The company searches for projects that could provide
potential above-market returns.
To learn more about Lexaria Corp. visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements. Such forward-looking statements are
estimates reflecting the Company's best judgment based upon current information
and involve a number of risks and uncertainties, and there can be no assurance
that other factors will not affect the accuracy of such forward-looking
statements. Access to capital, or lack thereof, is a major risk and there is no
assurance that the Company will be able to raise required working capital. Current oil and
gas production rates may not be sustainable and targeted production rates may
not occur. Factors which could cause actual results to differ materially from
those estimated by the Company include, but are not limited to, government
regulation, managing and maintaining growth, the effect of adverse publicity,
litigation, competition and other factors which may be identified from time to
time in the Company's public announcements and filings. There is no assurance
that the medical marijuana, CBD sector, or alternative health businesses will
provide any benefit to Lexaria, or that the Company will experience any growth
through participation in these sectors. There is no assurance that existing
capital is sufficient for the Company's needs or that it will need to attempt to
raise additional capital. There is no assurance that and cannabidiol-based
product will promote, assist, or maintain any beneficial human health conditions
whatsoever. No statement herein has been evaluated by the Food and Drug
Administration (FDA). PoViva products are not intended to diagnose, treat, cure
or prevent any disease.
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.